Global Drugs of UDCA and t-UDCA Supply, Demand and Key Producers, 2024-2030

Description

The global Drugs of UDCA and t-UDCA market size is expected to reach $ 3952.5 million by 2030, rising at a market growth of 12.2% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.

This report studies the global Drugs of UDCA and t-UDCA production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drugs of UDCA and t-UDCA, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs of UDCA and t-UDCA that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Drugs of UDCA and t-UDCA total production and demand, 2019-2030, (K Units)
Global Drugs of UDCA and t-UDCA total production value, 2019-2030, (USD Million)
Global Drugs of UDCA and t-UDCA production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Drugs of UDCA and t-UDCA consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Drugs of UDCA and t-UDCA domestic production, consumption, key domestic manufacturers and share
Global Drugs of UDCA and t-UDCA production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Drugs of UDCA and t-UDCA production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Drugs of UDCA and t-UDCA production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Drugs of UDCA and t-UDCA market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, Epic Pharma, Mitsubishi Tanabe Pharma, Lannett, Viatris, Bruschettini and Impax, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs of UDCA and t-UDCA market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Drugs of UDCA and t-UDCA Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Drugs of UDCA and t-UDCA Market, Segmentation by Type
    t-UDCA
    UDCA

Global Drugs of UDCA and t-UDCA Market, Segmentation by Application
    Gallstone
    Hepatopathy
    Biliary Disease
    Other

Companies Profiled:
    Dr. Falk Pharma
    Daewoong Pharmaceutical
    Teva
    Epic Pharma
    Mitsubishi Tanabe Pharma
    Lannett
    Viatris
    Bruschettini
    Impax
    Shanghai Pharma
    Grindeks

Key Questions Answered
1. How big is the global Drugs of UDCA and t-UDCA market?
2. What is the demand of the global Drugs of UDCA and t-UDCA market?
3. What is the year over year growth of the global Drugs of UDCA and t-UDCA market?
4. What is the production and production value of the global Drugs of UDCA and t-UDCA market?
5. Who are the key producers in the global Drugs of UDCA and t-UDCA market?

Table of Contents

1 Supply Summary
    1.1 Drugs of UDCA and t-UDCA Introduction
    1.2 World Drugs of UDCA and t-UDCA Supply & Forecast
        1.2.1 World Drugs of UDCA and t-UDCA Production Value (2019 & 2023 & 2030)
        1.2.2 World Drugs of UDCA and t-UDCA Production (2019-2030)
        1.2.3 World Drugs of UDCA and t-UDCA Pricing Trends (2019-2030)
    1.3 World Drugs of UDCA and t-UDCA Production by Region (Based on Production Site)
        1.3.1 World Drugs of UDCA and t-UDCA Production Value by Region (2019-2030)
        1.3.2 World Drugs of UDCA and t-UDCA Production by Region (2019-2030)
        1.3.3 World Drugs of UDCA and t-UDCA Average Price by Region (2019-2030)
        1.3.4 North America Drugs of UDCA and t-UDCA Production (2019-2030)
        1.3.5 Europe Drugs of UDCA and t-UDCA Production (2019-2030)
        1.3.6 China Drugs of UDCA and t-UDCA Production (2019-2030)
        1.3.7 Japan Drugs of UDCA and t-UDCA Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Drugs of UDCA and t-UDCA Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Drugs of UDCA and t-UDCA Major Market Trends

2 Demand Summary
    2.1 World Drugs of UDCA and t-UDCA Demand (2019-2030)
    2.2 World Drugs of UDCA and t-UDCA Consumption by Region
        2.2.1 World Drugs of UDCA and t-UDCA Consumption by Region (2019-2024)
        2.2.2 World Drugs of UDCA and t-UDCA Consumption Forecast by Region (2025-2030)
    2.3 United States Drugs of UDCA and t-UDCA Consumption (2019-2030)
    2.4 China Drugs of UDCA and t-UDCA Consumption (2019-2030)
    2.5 Europe Drugs of UDCA and t-UDCA Consumption (2019-2030)
    2.6 Japan Drugs of UDCA and t-UDCA Consumption (2019-2030)
    2.7 South Korea Drugs of UDCA and t-UDCA Consumption (2019-2030)
    2.8 ASEAN Drugs of UDCA and t-UDCA Consumption (2019-2030)
    2.9 India Drugs of UDCA and t-UDCA Consumption (2019-2030)

3 World Drugs of UDCA and t-UDCA Manufacturers Competitive Analysis
    3.1 World Drugs of UDCA and t-UDCA Production Value by Manufacturer (2019-2024)
    3.2 World Drugs of UDCA and t-UDCA Production by Manufacturer (2019-2024)
    3.3 World Drugs of UDCA and t-UDCA Average Price by Manufacturer (2019-2024)
    3.4 Drugs of UDCA and t-UDCA Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Drugs of UDCA and t-UDCA Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Drugs of UDCA and t-UDCA in 2023
        3.5.3 Global Concentration Ratios (CR8) for Drugs of UDCA and t-UDCA in 2023
    3.6 Drugs of UDCA and t-UDCA Market: Overall Company Footprint Analysis
        3.6.1 Drugs of UDCA and t-UDCA Market: Region Footprint
        3.6.2 Drugs of UDCA and t-UDCA Market: Company Product Type Footprint
        3.6.3 Drugs of UDCA and t-UDCA Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Drugs of UDCA and t-UDCA Production Value Comparison
        4.1.1 United States VS China: Drugs of UDCA and t-UDCA Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Drugs of UDCA and t-UDCA Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Drugs of UDCA and t-UDCA Production Comparison
        4.2.1 United States VS China: Drugs of UDCA and t-UDCA Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Drugs of UDCA and t-UDCA Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Drugs of UDCA and t-UDCA Consumption Comparison
        4.3.1 United States VS China: Drugs of UDCA and t-UDCA Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Drugs of UDCA and t-UDCA Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Drugs of UDCA and t-UDCA Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Drugs of UDCA and t-UDCA Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Drugs of UDCA and t-UDCA Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Drugs of UDCA and t-UDCA Production (2019-2024)
    4.5 China Based Drugs of UDCA and t-UDCA Manufacturers and Market Share
        4.5.1 China Based Drugs of UDCA and t-UDCA Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Drugs of UDCA and t-UDCA Production Value (2019-2024)
        4.5.3 China Based Manufacturers Drugs of UDCA and t-UDCA Production (2019-2024)
    4.6 Rest of World Based Drugs of UDCA and t-UDCA Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Drugs of UDCA and t-UDCA Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production (2019-2024)

5 Market Analysis by Type
    5.1 World Drugs of UDCA and t-UDCA Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 t-UDCA
        5.2.2 UDCA
    5.3 Market Segment by Type
        5.3.1 World Drugs of UDCA and t-UDCA Production by Type (2019-2030)
        5.3.2 World Drugs of UDCA and t-UDCA Production Value by Type (2019-2030)
        5.3.3 World Drugs of UDCA and t-UDCA Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Drugs of UDCA and t-UDCA Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Gallstone
        6.2.2 Hepatopathy
        6.2.3 Biliary Disease
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World Drugs of UDCA and t-UDCA Production by Application (2019-2030)
        6.3.2 World Drugs of UDCA and t-UDCA Production Value by Application (2019-2030)
        6.3.3 World Drugs of UDCA and t-UDCA Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Dr. Falk Pharma
        7.1.1 Dr. Falk Pharma Details
        7.1.2 Dr. Falk Pharma Major Business
        7.1.3 Dr. Falk Pharma Drugs of UDCA and t-UDCA Product and Services
        7.1.4 Dr. Falk Pharma Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Dr. Falk Pharma Recent Developments/Updates
        7.1.6 Dr. Falk Pharma Competitive Strengths & Weaknesses
    7.2 Daewoong Pharmaceutical
        7.2.1 Daewoong Pharmaceutical Details
        7.2.2 Daewoong Pharmaceutical Major Business
        7.2.3 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product and Services
        7.2.4 Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Daewoong Pharmaceutical Recent Developments/Updates
        7.2.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
    7.3 Teva
        7.3.1 Teva Details
        7.3.2 Teva Major Business
        7.3.3 Teva Drugs of UDCA and t-UDCA Product and Services
        7.3.4 Teva Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Teva Recent Developments/Updates
        7.3.6 Teva Competitive Strengths & Weaknesses
    7.4 Epic Pharma
        7.4.1 Epic Pharma Details
        7.4.2 Epic Pharma Major Business
        7.4.3 Epic Pharma Drugs of UDCA and t-UDCA Product and Services
        7.4.4 Epic Pharma Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Epic Pharma Recent Developments/Updates
        7.4.6 Epic Pharma Competitive Strengths & Weaknesses
    7.5 Mitsubishi Tanabe Pharma
        7.5.1 Mitsubishi Tanabe Pharma Details
        7.5.2 Mitsubishi Tanabe Pharma Major Business
        7.5.3 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product and Services
        7.5.4 Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
        7.5.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
    7.6 Lannett
        7.6.1 Lannett Details
        7.6.2 Lannett Major Business
        7.6.3 Lannett Drugs of UDCA and t-UDCA Product and Services
        7.6.4 Lannett Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Lannett Recent Developments/Updates
        7.6.6 Lannett Competitive Strengths & Weaknesses
    7.7 Viatris
        7.7.1 Viatris Details
        7.7.2 Viatris Major Business
        7.7.3 Viatris Drugs of UDCA and t-UDCA Product and Services
        7.7.4 Viatris Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Viatris Recent Developments/Updates
        7.7.6 Viatris Competitive Strengths & Weaknesses
    7.8 Bruschettini
        7.8.1 Bruschettini Details
        7.8.2 Bruschettini Major Business
        7.8.3 Bruschettini Drugs of UDCA and t-UDCA Product and Services
        7.8.4 Bruschettini Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Bruschettini Recent Developments/Updates
        7.8.6 Bruschettini Competitive Strengths & Weaknesses
    7.9 Impax
        7.9.1 Impax Details
        7.9.2 Impax Major Business
        7.9.3 Impax Drugs of UDCA and t-UDCA Product and Services
        7.9.4 Impax Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Impax Recent Developments/Updates
        7.9.6 Impax Competitive Strengths & Weaknesses
    7.10 Shanghai Pharma
        7.10.1 Shanghai Pharma Details
        7.10.2 Shanghai Pharma Major Business
        7.10.3 Shanghai Pharma Drugs of UDCA and t-UDCA Product and Services
        7.10.4 Shanghai Pharma Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Shanghai Pharma Recent Developments/Updates
        7.10.6 Shanghai Pharma Competitive Strengths & Weaknesses
    7.11 Grindeks
        7.11.1 Grindeks Details
        7.11.2 Grindeks Major Business
        7.11.3 Grindeks Drugs of UDCA and t-UDCA Product and Services
        7.11.4 Grindeks Drugs of UDCA and t-UDCA Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Grindeks Recent Developments/Updates
        7.11.6 Grindeks Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Drugs of UDCA and t-UDCA Industry Chain
    8.2 Drugs of UDCA and t-UDCA Upstream Analysis
        8.2.1 Drugs of UDCA and t-UDCA Core Raw Materials
        8.2.2 Main Manufacturers of Drugs of UDCA and t-UDCA Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Drugs of UDCA and t-UDCA Production Mode
    8.6 Drugs of UDCA and t-UDCA Procurement Model
    8.7 Drugs of UDCA and t-UDCA Industry Sales Model and Sales Channels
        8.7.1 Drugs of UDCA and t-UDCA Sales Model
        8.7.2 Drugs of UDCA and t-UDCA Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Drugs of UDCA and t-UDCA Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Drugs of UDCA and t-UDCA Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Drugs of UDCA and t-UDCA Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Drugs of UDCA and t-UDCA Production Value Market Share by Region (2019-2024)
    Table 5. World Drugs of UDCA and t-UDCA Production Value Market Share by Region (2025-2030)
    Table 6. World Drugs of UDCA and t-UDCA Production by Region (2019-2024) & (K Units)
    Table 7. World Drugs of UDCA and t-UDCA Production by Region (2025-2030) & (K Units)
    Table 8. World Drugs of UDCA and t-UDCA Production Market Share by Region (2019-2024)
    Table 9. World Drugs of UDCA and t-UDCA Production Market Share by Region (2025-2030)
    Table 10. World Drugs of UDCA and t-UDCA Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Drugs of UDCA and t-UDCA Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Drugs of UDCA and t-UDCA Major Market Trends
    Table 13. World Drugs of UDCA and t-UDCA Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Drugs of UDCA and t-UDCA Consumption by Region (2019-2024) & (K Units)
    Table 15. World Drugs of UDCA and t-UDCA Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Drugs of UDCA and t-UDCA Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Drugs of UDCA and t-UDCA Producers in 2023
    Table 18. World Drugs of UDCA and t-UDCA Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Drugs of UDCA and t-UDCA Producers in 2023
    Table 20. World Drugs of UDCA and t-UDCA Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Drugs of UDCA and t-UDCA Company Evaluation Quadrant
    Table 22. World Drugs of UDCA and t-UDCA Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Drugs of UDCA and t-UDCA Production Site of Key Manufacturer
    Table 24. Drugs of UDCA and t-UDCA Market: Company Product Type Footprint
    Table 25. Drugs of UDCA and t-UDCA Market: Company Product Application Footprint
    Table 26. Drugs of UDCA and t-UDCA Competitive Factors
    Table 27. Drugs of UDCA and t-UDCA New Entrant and Capacity Expansion Plans
    Table 28. Drugs of UDCA and t-UDCA Mergers & Acquisitions Activity
    Table 29. United States VS China Drugs of UDCA and t-UDCA Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Drugs of UDCA and t-UDCA Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Drugs of UDCA and t-UDCA Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Drugs of UDCA and t-UDCA Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Drugs of UDCA and t-UDCA Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Drugs of UDCA and t-UDCA Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Drugs of UDCA and t-UDCA Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Drugs of UDCA and t-UDCA Production Market Share (2019-2024)
    Table 37. China Based Drugs of UDCA and t-UDCA Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Drugs of UDCA and t-UDCA Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Drugs of UDCA and t-UDCA Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Drugs of UDCA and t-UDCA Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Drugs of UDCA and t-UDCA Production Market Share (2019-2024)
    Table 42. Rest of World Based Drugs of UDCA and t-UDCA Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production Market Share (2019-2024)
    Table 47. World Drugs of UDCA and t-UDCA Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Drugs of UDCA and t-UDCA Production by Type (2019-2024) & (K Units)
    Table 49. World Drugs of UDCA and t-UDCA Production by Type (2025-2030) & (K Units)
    Table 50. World Drugs of UDCA and t-UDCA Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Drugs of UDCA and t-UDCA Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Drugs of UDCA and t-UDCA Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Drugs of UDCA and t-UDCA Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Drugs of UDCA and t-UDCA Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Drugs of UDCA and t-UDCA Production by Application (2019-2024) & (K Units)
    Table 56. World Drugs of UDCA and t-UDCA Production by Application (2025-2030) & (K Units)
    Table 57. World Drugs of UDCA and t-UDCA Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Drugs of UDCA and t-UDCA Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Drugs of UDCA and t-UDCA Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Drugs of UDCA and t-UDCA Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Dr. Falk Pharma Basic Information, Manufacturing Base and Competitors
    Table 62. Dr. Falk Pharma Major Business
    Table 63. Dr. Falk Pharma Drugs of UDCA and t-UDCA Product and Services
    Table 64. Dr. Falk Pharma Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Dr. Falk Pharma Recent Developments/Updates
    Table 66. Dr. Falk Pharma Competitive Strengths & Weaknesses
    Table 67. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 68. Daewoong Pharmaceutical Major Business
    Table 69. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Product and Services
    Table 70. Daewoong Pharmaceutical Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Daewoong Pharmaceutical Recent Developments/Updates
    Table 72. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
    Table 73. Teva Basic Information, Manufacturing Base and Competitors
    Table 74. Teva Major Business
    Table 75. Teva Drugs of UDCA and t-UDCA Product and Services
    Table 76. Teva Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Teva Recent Developments/Updates
    Table 78. Teva Competitive Strengths & Weaknesses
    Table 79. Epic Pharma Basic Information, Manufacturing Base and Competitors
    Table 80. Epic Pharma Major Business
    Table 81. Epic Pharma Drugs of UDCA and t-UDCA Product and Services
    Table 82. Epic Pharma Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Epic Pharma Recent Developments/Updates
    Table 84. Epic Pharma Competitive Strengths & Weaknesses
    Table 85. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
    Table 86. Mitsubishi Tanabe Pharma Major Business
    Table 87. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Product and Services
    Table 88. Mitsubishi Tanabe Pharma Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Mitsubishi Tanabe Pharma Recent Developments/Updates
    Table 90. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
    Table 91. Lannett Basic Information, Manufacturing Base and Competitors
    Table 92. Lannett Major Business
    Table 93. Lannett Drugs of UDCA and t-UDCA Product and Services
    Table 94. Lannett Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Lannett Recent Developments/Updates
    Table 96. Lannett Competitive Strengths & Weaknesses
    Table 97. Viatris Basic Information, Manufacturing Base and Competitors
    Table 98. Viatris Major Business
    Table 99. Viatris Drugs of UDCA and t-UDCA Product and Services
    Table 100. Viatris Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Viatris Recent Developments/Updates
    Table 102. Viatris Competitive Strengths & Weaknesses
    Table 103. Bruschettini Basic Information, Manufacturing Base and Competitors
    Table 104. Bruschettini Major Business
    Table 105. Bruschettini Drugs of UDCA and t-UDCA Product and Services
    Table 106. Bruschettini Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Bruschettini Recent Developments/Updates
    Table 108. Bruschettini Competitive Strengths & Weaknesses
    Table 109. Impax Basic Information, Manufacturing Base and Competitors
    Table 110. Impax Major Business
    Table 111. Impax Drugs of UDCA and t-UDCA Product and Services
    Table 112. Impax Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Impax Recent Developments/Updates
    Table 114. Impax Competitive Strengths & Weaknesses
    Table 115. Shanghai Pharma Basic Information, Manufacturing Base and Competitors
    Table 116. Shanghai Pharma Major Business
    Table 117. Shanghai Pharma Drugs of UDCA and t-UDCA Product and Services
    Table 118. Shanghai Pharma Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Shanghai Pharma Recent Developments/Updates
    Table 120. Grindeks Basic Information, Manufacturing Base and Competitors
    Table 121. Grindeks Major Business
    Table 122. Grindeks Drugs of UDCA and t-UDCA Product and Services
    Table 123. Grindeks Drugs of UDCA and t-UDCA Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 124. Global Key Players of Drugs of UDCA and t-UDCA Upstream (Raw Materials)
    Table 125. Drugs of UDCA and t-UDCA Typical Customers
    Table 126. Drugs of UDCA and t-UDCA Typical Distributors
List of Figure
    Figure 1. Drugs of UDCA and t-UDCA Picture
    Figure 2. World Drugs of UDCA and t-UDCA Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Drugs of UDCA and t-UDCA Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Drugs of UDCA and t-UDCA Production (2019-2030) & (K Units)
    Figure 5. World Drugs of UDCA and t-UDCA Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Drugs of UDCA and t-UDCA Production Value Market Share by Region (2019-2030)
    Figure 7. World Drugs of UDCA and t-UDCA Production Market Share by Region (2019-2030)
    Figure 8. North America Drugs of UDCA and t-UDCA Production (2019-2030) & (K Units)
    Figure 9. Europe Drugs of UDCA and t-UDCA Production (2019-2030) & (K Units)
    Figure 10. China Drugs of UDCA and t-UDCA Production (2019-2030) & (K Units)
    Figure 11. Japan Drugs of UDCA and t-UDCA Production (2019-2030) & (K Units)
    Figure 12. Drugs of UDCA and t-UDCA Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 15. World Drugs of UDCA and t-UDCA Consumption Market Share by Region (2019-2030)
    Figure 16. United States Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 17. China Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 18. Europe Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 19. Japan Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 22. India Drugs of UDCA and t-UDCA Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Drugs of UDCA and t-UDCA by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Drugs of UDCA and t-UDCA Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Drugs of UDCA and t-UDCA Markets in 2023
    Figure 26. United States VS China: Drugs of UDCA and t-UDCA Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Drugs of UDCA and t-UDCA Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Drugs of UDCA and t-UDCA Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Drugs of UDCA and t-UDCA Production Market Share 2023
    Figure 30. China Based Manufacturers Drugs of UDCA and t-UDCA Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Drugs of UDCA and t-UDCA Production Market Share 2023
    Figure 32. World Drugs of UDCA and t-UDCA Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Drugs of UDCA and t-UDCA Production Value Market Share by Type in 2023
    Figure 34. t-UDCA
    Figure 35. UDCA
    Figure 36. World Drugs of UDCA and t-UDCA Production Market Share by Type (2019-2030)
    Figure 37. World Drugs of UDCA and t-UDCA Production Value Market Share by Type (2019-2030)
    Figure 38. World Drugs of UDCA and t-UDCA Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Drugs of UDCA and t-UDCA Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Drugs of UDCA and t-UDCA Production Value Market Share by Application in 2023
    Figure 41. Gallstone
    Figure 42. Hepatopathy
    Figure 43. Biliary Disease
    Figure 44. Other
    Figure 45. World Drugs of UDCA and t-UDCA Production Market Share by Application (2019-2030)
    Figure 46. World Drugs of UDCA and t-UDCA Production Value Market Share by Application (2019-2030)
    Figure 47. World Drugs of UDCA and t-UDCA Average Price by Application (2019-2030) & (US$/Unit)
    Figure 48. Drugs of UDCA and t-UDCA Industry Chain
    Figure 49. Drugs of UDCA and t-UDCA Procurement Model
    Figure 50. Drugs of UDCA and t-UDCA Sales Model
    Figure 51. Drugs of UDCA and t-UDCA Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Companies Mentioned

Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Viatris
Bruschettini
Impax
Shanghai Pharma
Grindeks